Age-related clonal hematopoiesis associated with adverse outcomes - Test2 - elhamkhani - TriplyDB

Age-related clonal hematopoiesis associated with adverse outcomes

Age-related clonal hematopoiesis associated with adverse outcomes

http://www.wikidata.org/entity/Q28386602

about

Aging of hematopoietic stem cells: DNA damage and mutations?Immune Mechanisms in Myelodysplastic Syndrome The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities Recent advances in understanding myelofibrosis and essential thrombocythemia How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis Personalized Cancer Risk Assessments for Space Radiation Exposures Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies When stem cells grow old: phenotypes and mechanisms of stem cell aging Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance An update of current treatments for adult acute myeloid leukemia Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?Deconstructing innate immune signaling in myelodysplastic syndromes Somatic mosaicism: implications for disease and transmission genetics Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis.Genomic Classification and Prognosis in Acute Myeloid Leukemia.Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome Role of TET enzymes in DNA methylation, development, and cancer Therapy-related myeloid neoplasms - what have we learned so far?New insights into the generation and role of de novo mutations in health and disease DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment Clonal hematopoiesis in acquired aplastic anemia Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology Application of single-cell genomics in cancer: promise and challenges Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations Stochastic modeling reveals an evolutionary mechanism underlying elevated rates of childhood leukemia Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer

P2860

Q26741217-C0EC6C03-EC90-4485-8967-D2D97BF18CB4 Q26744500-C3C5236B-7B21-4F93-A790-95C34212A10B Q26744506-7657A440-2D17-4DD5-ADE5-5606749E4A79 Q26748543-11C66309-618F-44DB-803F-C7B88FA2C2CB Q26748867-68339CAE-23F4-4F4C-A159-489A708BBA10 Q26751011-205FDF17-5C96-4D34-BA19-ADA8384002C1 Q26752221-64D006DD-1AEB-4AD3-8367-5B814407F873 Q26768260-6D95F1D4-77D6-4F56-B0DB-57C6EF1C0C28 Q26770394-5D5A7478-CE75-474A-93CD-968F351C0D44 Q26770845-B7506294-ABFB-4F3D-AFA7-ECBF3369DF7A Q26772881-CB06E181-C0C0-4400-BCD9-A3EECE238182 Q26776393-0D4E8D10-D5EB-465D-A776-091FFC312828 Q26776396-BFDA740B-D4DF-4E4E-AF50-298257521EFB Q26779936-36A46BC6-BC66-4269-A037-E78E9DC2CDA9 Q26796240-6862B241-8D82-498C-BA18-FFD4D4386AFA Q26801573-27A7120D-8E7D-4A69-A040-9673AD352F4C Q26991974-714D0E02-8CC2-45DF-A887-D5B244DA1F95 Q27016060-B090DC98-0309-4249-9AE4-9082E237ACB1 Q27308738-DC6C91AB-9637-4EA8-BBBA-E9B69941BA55 Q27853389-0CC84399-FA8C-4B7B-95A8-83CB8ADCE5A7 Q27908479-EA8315D2-7264-46C8-A5F4-E9A461BEA00B Q28068541-B8078382-BA39-43CC-AE79-82E1CCAA1955 Q28071318-D935FDA1-7815-4D38-846B-FA2915C48A1A Q28073446-483C1C26-4A2A-401D-93F2-3B4FE19C95DC Q28073970-34C15E26-2193-4A6A-BBCA-AB5531C27AEC Q28074446-2E805586-52B6-41CD-A0ED-BD04EC0AA096 Q28079733-30DA6F69-3FE0-4177-9182-51E6ED6C0A8B Q28080945-193AFDAB-32A3-46DE-BB82-143547522990 Q28085411-919A6565-16DF-4B3D-B69D-33A5014328C8 Q28087291-488B762D-6809-4387-8AB4-309C4FEC3E44 Q28087672-CC907542-1F5A-448B-BF41-FE3B5E2FE0AB Q28263098-E65E6EC6-8DB3-4E1E-B511-6D865B462B32 Q28383417-BA5B46A7-5EEC-4B2C-836C-1A880580F721 Q28384025-16B87914-E899-4845-A5A1-955E31B6C61C Q28384546-91DD283F-093F-4F3B-A45E-A9FC6D650B5E Q28386119-BE9924AA-BAAF-4995-8D50-D2579A178D16 Q28386212-83EAD840-12DC-4E2A-8D22-9D15FECAE071 Q28387115-79443AA2-464D-4400-AA4A-F5EE9A9AE8E2 Q28389979-ADE845E1-798C-493C-B755-902C9DECBE47 Q28390093-750141C3-276E-46AD-BA65-D7AFABFAD8D5

P2860

Age-related clonal hematopoiesis associated with adverse outcomes

http://www.wikidata.org/entity/Q28386602

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Age-related clonal hematopoiesis associated with adverse outcomes

@ast

Age-related clonal hematopoiesis associated with adverse outcomes

@en

Age-related clonal hematopoiesis associated with adverse outcomes

@nl

type

label

Age-related clonal hematopoiesis associated with adverse outcomes

@ast

Age-related clonal hematopoiesis associated with adverse outcomes

@en

Age-related clonal hematopoiesis associated with adverse outcomes

@nl

prefLabel

Age-related clonal hematopoiesis associated with adverse outcomes

@ast

Age-related clonal hematopoiesis associated with adverse outcomes

@en

Age-related clonal hematopoiesis associated with adverse outcomes

@nl

P1433

Q28386602-BB477E4B-41E7-4323-83F0-D8535DCE261A

P1476

Q28386602-19141728-0059-4C15-B903-FE1E7F04E42B

P2093

Q28386602-0ACD44C7-B877-4A66-BDBD-6C209A794981

Q28386602-0C664DF8-4300-4A13-8846-93A032C27FE5

Q28386602-18A7D156-9756-4AA7-9B60-29A11A177957

Q28386602-265024E8-AD5B-40DD-9202-566CC55D5F6A

Q28386602-2836BA7C-5D1B-4281-9CB3-3953763992EC

Q28386602-29A03E9C-A79C-4E15-A904-1B0ACA390F47

Q28386602-3A3D847F-9A1D-4C3B-BC7A-16D304A42750

Q28386602-4520567D-6715-4C0A-AB9B-9D368AEAF926

Q28386602-52A5CA12-9BEE-4BD6-BE53-9E3083CE2082

Q28386602-6ADF4846-8310-4254-A85F-0E45122A2032

P2860

Q28386602-09810195-4658-4B4C-B03E-5EB6E7DC2821

Q28386602-16137A25-3FE3-46D0-BD4D-CE29655B9E51

Q28386602-183B52F1-C5F7-4EB7-8CDE-2326429BB66F

Q28386602-199C6326-6D03-4B7B-831D-88E82B805C77

Q28386602-25CD26D4-E146-4B44-A333-F7BA5D0EBAC1

Q28386602-26D8AA61-9ECE-49AD-BBFA-AFBAFC6FB78D

Q28386602-2C5AFBF6-27A1-48A4-8258-711C244AF015

Q28386602-32D9C193-35A6-405B-A116-F43642749E33

Q28386602-34C065FA-56CB-4E4F-A56A-EF1AB52E7426

Q28386602-35610404-A8E3-4866-A654-0C6CE15828F8

P304

Q28386602-8CDAD609-09EB-4673-B40D-90297F4A5C43

P31

Q28386602-F2DB61D3-2F48-465A-A743-53D1A857A4F0

P3181

Q28386602-94FE97AD-653F-47CD-9E1A-0BC132369437

P356

Q28386602-90A76D00-3B51-4812-A459-E8BA25EB0EA4

P407

Q28386602-2938A95B-F1E7-4C4C-A879-57E7ABED9EC3

P433

Q28386602-F6F5F623-10FF-479F-A6D0-81EDF462B263

P478

Q28386602-ED46A2BD-8BD4-449F-AAD7-8A88E05FEAAF

P50

Q28386602-0FDB93EB-F52D-4C3D-BA7B-5ACB213BE266

Q28386602-34BF8B99-3B90-45D0-9A0A-873A63405E96

Q28386602-3580E1B9-FD38-46DC-B186-F24A1A7D9043

Q28386602-41591465-70F9-408D-943E-B8EE82C7555A

Q28386602-542A01B7-80C1-40BB-A450-88AF889797D8

Q28386602-5E330992-0EC9-41D3-BD8C-C54AD09479F7

Q28386602-67FE2C9B-C957-4CC7-9794-A2396DFD3C4A

Q28386602-6EED0301-482F-4165-8E9A-F092EE37F172

Q28386602-70D6C042-C114-4D9D-BBEE-625F8E3F5958

Q28386602-77812FC1-4216-43FF-9A0E-F77AA8C3E82A

P577

Q28386602-06B67F4A-7FD5-4F65-8BA1-034C391537E4

P5875

Q28386602-6BD26B3D-DEB9-4CAF-9F13-7986F59A5A02

P698

Q28386602-07043AFC-FF5A-4E13-9723-2DED7DE530B8

P921

Q28386602-095FEE41-4F3F-4D81-9017-BB09A28E150C

P932

Q28386602-6478FD82-C25D-41B7-A790-BEA2B5521453

P3181

P356

P1433

The New England Journal of Medicine

P1476

Age-related clonal hematopoiesis associated with adverse outcomes

@en

P2093

Adolfo Correa

http://www.w3.org/2001/XMLSchema#string

Alejandro Chavez

http://www.w3.org/2001/XMLSchema#string

Alisa Manning

http://www.w3.org/2001/XMLSchema#string

Benjamin F Banahan

http://www.w3.org/2001/XMLSchema#string

Benjamin L Ebert

http://www.w3.org/2001/XMLSchema#string

Claes Ladenvall

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Frank C Kuo

http://www.w3.org/2001/XMLSchema#string

James G Wilson

http://www.w3.org/2001/XMLSchema#string

Jason Flannick

http://www.w3.org/2001/XMLSchema#string

P2860

Detectable clonal mosaicism and its relationship to aging and cancer

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Recurring mutations found by sequencing an acute myeloid leukemia genome

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

The clonal evolution of tumor cell populations

Discovery and saturation analysis of cancer genes across 21 tumour types

Detectable clonal mosaicism from birth to old age and its relationship to cancer

Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells

P304

2488-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

763932

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1408617

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P50

Sekar Kathiresan

Jaakko Tuomilehto

Pierre Fontanillas

Heikki A. Koistinen

David Altshuler

P577

2014-12-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268874174

http://www.w3.org/2001/XMLSchema#string

P698

25426837

http://www.w3.org/2001/XMLSchema#string

P921

P932

4306669

http://www.w3.org/2001/XMLSchema#string